Technology And Equipment Tenders

Conclusion of a Non-Exclusive Framework Agreement for Control Tests and Preliminary Investigations in the Open House Procedure of the Southwest Branch, Published in 2023

Supported Living Fps

Care and Supervision for Children in Foster Care with Parents Receiving Treatment

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Teriparatide (H05aa02) as Part of a So-Called Open House Model.

Purchase of Wood Pellets and Coal to Create a Dynamic Purchasing System

Open House Contracts for Several Active Ingredients/Combinations of Active Ingredients

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Piribedil (N04bc08) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Purposes Described in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open Hous...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredients Formoterol and Fluticasone (R03ak11) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Tamoxifen (L02ba01) as Part of a So-Called Open House Model.